Gene of the issue: <i>ANO6</i> and Scott Syndrome

Sarah L. Millington‐Burgess, Matthew T. Harper

Platelets · 2019 · 37 citations · 38 references

DOIFull text

Open access

Concepts

Abstract

Scott Syndrome is a very rare inhibited bleeding disorder characterised by an isolated deficit in procoagulant activity in platelets and other blood cells, caused by a lack of phosphatidylserine (PS) exposure following activation.[1,2] It results from mutations in ANO6, which encodes the phospholipid scramblase protein, TMEM16F.[3]

References

38